DNPUF fundamentals
An in-depth look to DAI Nippon Pharmaceutical operating, investing, and financing activities
DNPUF free cash flow for Q4 23 is -102.02 M USD. For 2023, DNPUF free cash flow was -1.67 B USD and operating cash flow was -1.6 B USD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM